Hims & Hers COO sells 13,750 shares at $36.71 in plan trade
Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported selling 13,750 shares of Class A common stock on 12/17/2025 at $36.71 per share.
Rhea-AI Filing Summary
Hims & Hers Health, Inc. Chief Operating Officer Michael Chi reported selling 13,750 shares of Class A common stock on 12/17/2025 at $36.71 per share. The transaction was reported with transaction code "S" and was effected under a Rule 10b5-1 trading plan adopted on March 4, 2025.
After this sale, Chi beneficially owns 305,161 shares of Hims & Hers Health, Inc. common stock in direct ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Class A Common Stock | 13,750 | $36.71 | $505K |
Footnotes (1)
- F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on March 4, 2025 by the Reporting Person.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Hims & Hers Health (HIMS) disclose?
Hims & Hers Health, Inc. disclosed that Chief Operating Officer Michael Chi reported a sale of Class A common stock in a recent insider transaction.
When did the Hims & Hers (HIMS) COO stock sale occur?
The reported sale by Hims & Hers Health, Inc. COO Michael Chi took place on 12/17/2025.
Was the Hims & Hers (HIMS) insider sale made under a Rule 10b5-1 trading plan?
Yes. The filing states that the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Michael Chi on March 4, 2025.
What is the role of the reporting person at Hims & Hers Health (HIMS)?
The reporting person, Michael Chi, is an officer of Hims & Hers Health, Inc., serving as Chief Operating Officer.
AI-generated analysis. How Rhea-AI works. Not financial advice.